These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17447340)

  • 1. [Significance of gastrointestinal antibiotics in gastrointestinal diseases: Normix, the non-absorbable antibiotic].
    Orv Hetil; 2006 Oct; 147(42):2055-6. PubMed ID: 17447340
    [No Abstract]   [Full Text] [Related]  

  • 2. Gut flora and hepatic encephalopathy in patients with cirrhosis.
    Riordan SM; Williams R
    N Engl J Med; 2010 Mar; 362(12):1140-2. PubMed ID: 20335591
    [No Abstract]   [Full Text] [Related]  

  • 3. Rifaximin treatment in hepatic encephalopathy.
    Wang CC; Kao JH
    N Engl J Med; 2010 Jun; 362(25):2423; author reply 2424-5. PubMed ID: 20573932
    [No Abstract]   [Full Text] [Related]  

  • 4. Rifaximin treatment in hepatic encephalopathy.
    Sharma P; Sharma BC
    N Engl J Med; 2010 Jun; 362(25):2423-4; author reply 2424-5. PubMed ID: 20578274
    [No Abstract]   [Full Text] [Related]  

  • 5. Rifaximin treatment in hepatic encephalopathy.
    Xue T; Qiu JH; Qiao L
    N Engl J Med; 2010 Jun; 362(25):2424; author reply 2424-5. PubMed ID: 20578275
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical and pharmacological aspects of rifaximin, local antibiotic therapy in intestinal disorders].
    Gasztonyi B; Hunyady B
    Orv Hetil; 2004 Oct; 145(43):2177-81. PubMed ID: 15575494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatic encephalopathy and liver transplantation].
    Fehérvári I; Nemes B; Görög D; Gerlei Z; Kóbori L
    Magy Seb; 2012 Apr; 65(2):58-62. PubMed ID: 22512880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifaximin: a novel nonabsorbed rifamycin for gastrointestinal disorders.
    Adachi JA; DuPont HL
    Clin Infect Dis; 2006 Feb; 42(4):541-7. PubMed ID: 16421799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rifaximin in the treatment of hepatic encephalopathy].
    Lata J; Hůlek P; Fejfar T; Spicák J; Drastich P; Marecek Z; Brůha R; Husová L; Senkyrík M
    Vnitr Lek; 2002 Jun; 48(6):578-82. PubMed ID: 12132365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intestine specific broad spectrum antibiotic. Rifaximin: therapy option in hepatic encephalopathy].
    MMW Fortschr Med; 2014 Feb; 156(3):64-5. PubMed ID: 24938070
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications.
    Ponziani FR; Gerardi V; Pecere S; D'Aversa F; Lopetuso L; Zocco MA; Pompili M; Gasbarrini A
    World J Gastroenterol; 2015 Nov; 21(43):12322-33. PubMed ID: 26604640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifaximin therapy in minimal hepatic encephalopathy cirrhotics.
    Zullo A; Hassan C; Lorenzetti R
    Am J Gastroenterol; 2011 Nov; 106(11):2041; author reply 2041-2. PubMed ID: 22056578
    [No Abstract]   [Full Text] [Related]  

  • 13. Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis.
    Prakash RK; Kanna S; Mullen KD
    Clin Ther; 2013 Sep; 35(9):1458-73. PubMed ID: 23972578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: prolonged remission from hepatic encephalopathy with rifaximin.
    Orr JG; Hudson M
    Aliment Pharmacol Ther; 2015 Jan; 41(2):228. PubMed ID: 25511766
    [No Abstract]   [Full Text] [Related]  

  • 15. Durability of rifaximin response in hepatic encephalopathy.
    Neff GW; Jones M; Broda T; Jonas M; Ravi R; Novick D; Kaiser TE; Kemmer N
    J Clin Gastroenterol; 2012 Feb; 46(2):168-71. PubMed ID: 22011586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: rifaximin and minimal hepatic encephalopathy.
    Butterworth RF
    Am J Gastroenterol; 2011 Feb; 106(2):317-8. PubMed ID: 21301455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifaximin: a nonabsorbed oral antibiotic.
    Baker DE
    Rev Gastroenterol Disord; 2005; 5(1):19-30. PubMed ID: 15741929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesalazine and rifaximin in symptomatic uncomplicated diverticular disease.
    Festi D; Colecchia A
    Am J Gastroenterol; 2009 Feb; 104(2):532. PubMed ID: 19174809
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of hepatic encephalopathy].
    Morillas RM; Sala M; Planas R
    Med Clin (Barc); 2014 Jun; 142(11):512-4. PubMed ID: 24480288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on management of patients with overt hepatic encephalopathy.
    Chacko KR; Sigal SH
    Hosp Pract (1995); 2013 Aug; 41(3):48-59. PubMed ID: 23948621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.